Junjiro Ohshima Selected Research

Junjiro Ohshima Research Topics

6	Neoplasms (Cancer) 07/2016 - 08/2008
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2022 - 04/2012
3	Leukemia 10/2021 - 04/2012
1	Cytomegalovirus Infections (Inclusion Disease) 10/2022
1	Lymphoma (Lymphomas) 10/2021
1	Infections 03/2019
1	Sepsis (Septicemia) 03/2019
1	Rhabdomyosarcoma 07/2016
1	Residual Neoplasm 07/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2016
1	Wilms Tumor (Wilm's Tumor) 09/2012
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 08/2012
1	Germinoma 08/2012
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2012
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 04/2012
1	Febrile Neutropenia 12/2011
1	Neutropenia 12/2011
1	Fever (Fevers) 12/2011
1	Teratoma (Teratoid Tumor) 04/2009
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 04/2009
1	Seminoma 04/2009
1	Uniparental Disomy 08/2008

1	Busulfan (Busulfex)FDA Link 09/2019
1	Povidone-Iodine (Betadine)FDA LinkGeneric 03/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 07/2016
1	Melphalan (Alkeran)FDA LinkGeneric 07/2016
1	Methotrexate (Mexate)FDA LinkGeneric 02/2016
1	Tumor Necrosis Factor InhibitorsIBA 08/2012
1	Infliximab (Remicade)FDA Link 08/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012
1	Vincristine (Oncovin)FDA LinkGeneric 04/2012
1	Vindesine (Vindesin)IBA 04/2012
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 12/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2011
1	CefozopranIBA 12/2011
1	snRNP Core ProteinsIBA 04/2009
1	Messenger RNA (mRNA)IBA 08/2008

4	Therapeutics 10/2022 - 12/2011
3	Drug Therapy (Chemotherapy) 10/2021 - 07/2016
2	Hematopoietic Stem Cell Transplantation 10/2021 - 09/2019
1	Catheters 03/2019
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 07/2016
1	Ventriculostomy 07/2016
1	Transplantation 02/2016